Skip to main content

Valneva SE (INRLF) Stock

Valneva SE Stock Details, Movements and Public Alerts

Stock Details

Valneva SE (INRLF), a prominent company in the healthcare sector within the biotechnology industry, is based in France and primarily trades on the PNK.Currently, the stock is trading at $4.26. Over the past 52 weeks, it has ranged between $1.88 and $6.28. This places the current price at 67.8% of its 52-week high and 126.6% above its 52-week low. 0The 14-day Relative Strength Index (RSI) stands at 31.05, suggesting neutral conditions. The stock is currently trading below its 50-day moving average of $4.70 by 9.36%. Similarly, it is above its 200-day moving average of $3.89 by 9.51%. The MACD histogram is 0.01, indicating bullish momentum (MACD Line: -0.10, Signal Line: -0.11). There is currently 1 active alert set for INRLF by users.

52-Week Range

$6.28 - $1.88

-32.17% from high · +126.60% from low

Avg Daily Volume

506

20-day average

100-day avg: 412

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Price to Book

5.13

EV/EBITDA

-14.23

EPS (TTM)

-$0.75

Price to Sales

4.13

Beta

1.28

Similar volatility to market

How is INRLF valued relative to its earnings and growth?
Valuation data is not available for this stock.
What is INRLF's risk profile compared to the market?
With a beta of 1.28, Valneva SE is roughly as volatile as the market, moving in line with broad market trends. This moderate beta suggests the stock offers market-level returns without excessive volatility. The price-to-book ratio of 5.13 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

-56.78%

Operating Margin

-126.99%

EBITDA

$-57,881,000

Return on Equity

-55.53%

Return on Assets

-9.64%

Revenue Growth (YoY)

-35.80%

How profitable and efficient is INRLF's business model?
Valneva SE achieves a profit margin of -56.78%, meaning it retains $-56.78 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of -126.99% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -55.53% and ROA at -9.64%, the company achieves moderate returns on invested capital.
What are INRLF's recent growth trends?
Valneva SE's revenue declined by 35.80% year-over-year, indicating challenges in maintaining sales momentum. This contraction may reflect market headwinds, competitive pressures, or strategic transitions. These growth metrics should be evaluated against Biotechnology industry averages for proper context.

Company Size & Market

Market Cap

$743.8M

Revenue (TTM)

$179.91M

Revenue/Share (TTM)

$1.07

Shares Outstanding

171.83M

Book Value/Share

$0.83

Asset Type

EQUITY

What is INRLF's market capitalization and position?
Valneva SE has a market capitalization of $743.8M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 171.83M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Biotechnology industry, it competes with other firms in this sector.
How does INRLF's price compare to its book value?
Valneva SE's book value per share is $0.83, while the current stock price is $4.26, resulting in a price-to-book (P/B) ratio of 5.13. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As EQUITY, this represents a specific type of security.

Fundamentals last updated: Dec 1, 2025, 02:04 AM

Technical Indicators

RSI (14-day)

31.05

Neutral

50-Day Moving Average

$4.70

-9.36% below MA-50

200-Day Moving Average

$3.89

9.51% above MA-200

MACD Line

-0.10

MACD Signal

-0.11

MACD Histogram

0.01

Bullish

What does INRLF's RSI value tell investors?
The RSI (Relative Strength Index) for INRLF is currently 31.05, indicating the stock is showing bearish momentum (30-40 range). Selling pressure is evident but not extreme. This often occurs during pullbacks in uptrends or early stages of downtrends. Combined with the price being below the 50-day moving average, this confirms bearish conditions.
How should traders interpret INRLF's MACD and moving average crossovers?
MACD analysis shows the MACD line at -0.10 above the signal line at -0.11, with histogram at 0.01. This bullish crossover suggests upward momentum is building. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($4.70) is above the 200-day MA ($3.89), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently between the MAs, suggesting transition.

Indicators last updated: Dec 12, 2025, 12:55 AM

Active Alerts

Alert Condition
MA Breakout (Bullish)
Threshold
50 days
Created
Nov 26, 2025, 05:38 PM

Stay Ahead of the Market with Valneva SE Alerts

Set up price alerts for Valneva SE and get notified instantly when the price hits your target. Never miss an important price movement again.